Related Experiment Videos
Abstract:
Drug-induced diseases constitute up to 5% of hospital admissions,a figure which almost certainly understates the total morbidity due to drugs1. Sever drug-induced myopathies are uncommon, but milder forms may be more prevalent than is generally appreciated, since skeletal muscle constitutes some 45% of total body-weight and has a major metabolic role in addition to its mechanical function2. Knowledge of possible effects of drugs on the neuromuscular system is of increasing importance both because the range of therapeutic agents continues to expand and because the resulting syndromes, through usually reversible at the outset, may progress and lead to grave consequences if the drug responsible is not stopped. Drug-induced neuropathies3 will not be considered here, but it will be appreciated that muscle weakness may also be feature of such disorders and that some drugs may cause both a neuropathy and a myopathy. The features of the main drug-induced syndromes are summarised in the table. To these one could justifiably add the unwanted effects of srugs given for the treatment of central-nervous-system or neuromuscular disorders per se-e.g., the cholinergic block which may be produced by anticholinesterases alone or with corticosteroids in the myasthenic,4 and the profound weakness which may supervene after relief of spasticity with dantrolene sodium5.
Insights
Drug-induced myopathies, though uncommon, may be more prevalent than recognized. Prompt identification and cessation of causative drugs are crucial to prevent severe neuromuscular complications.
Area of Science:
- Neurology
- Pharmacology
- Internal Medicine
Background:
- Drug-induced diseases account for a significant percentage of hospital admissions, potentially underestimating total drug-related morbidity.
- Skeletal muscle, comprising 45% of body weight and playing a vital metabolic role, is susceptible to drug-induced effects.
- Understanding drug impacts on the neuromuscular system is increasingly vital due to expanding therapeutic options.
Purpose of the Study:
- To review the main drug-induced neuromuscular syndromes.
- To highlight the importance of recognizing and managing drug-induced myopathies.
- To differentiate myopathies from drug-induced neuropathies, while acknowledging potential overlap.
Main Methods:
- Review of existing literature on drug-induced myopathies and neuropathies.
- Summarization of key features of major drug-induced neuromuscular syndromes.
- Inclusion of specific examples of drug effects in conditions like myasthenia gravis and spasticity.
Main Results:
- Drug-induced myopathies, while less common than other drug toxicities, may be underdiagnosed.
- Milder forms of myopathy could be more prevalent due to the large mass and metabolic function of skeletal muscle.
- Some drugs can induce both myopathic and neuropathic conditions.
Conclusions:
- Early recognition and discontinuation of offending agents are critical for managing drug-induced myopathies.
- Drug-induced neuromuscular syndromes, if untreated, can progress from reversible conditions to severe outcomes.
- Awareness of drug effects on the neuromuscular system is essential for clinicians managing diverse patient populations.